Severe Pseudomonas aeruginosa infections: Tackling the conundrum of drug resistance
作者： Alan R. Hauser , Padman Sriram
关键词:
摘要: Pseudomonas aeruginosa infections are a frequent cause of morbidity and mortality in hospitalized patients. Treatment these is complicated by the intrinsic acquired resistance this bacterium to many commonly used antimicrobial agents. In article, Drs Hauser Sriram argue that careful consideration mechanisms which P. resists activity agents essential for optimal treatment decisions. Although aspects severe remain controversial, authors suggest specific options patients both before after susceptibilities known.
sci-hub.se 参考文章(26)
William R. Jarvis, Epidemiology and Control of Pseudomonas Aeruginosa Infections in the Intensive Care Unit Springer, Boston, MA. pp. 153- 168 ,(2003) , 10.1007/978-1-4615-0433-7_10
P. H. Chandrasekar, L. R. Crane, E. J. Bailey, Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients Journal of Antimicrobial Chemotherapy. ,vol. 19, pp. 321- 329 ,(1987) , 10.1093/JAC/19.3.321
G. S. Itokazu, J. P. Quinn, C. Bell-Dixon, F. M. Kahan, R. A. Weinstein, Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance Program Clinical Infectious Diseases. ,vol. 23, pp. 779- 784 ,(1996) , 10.1093/CLINIDS/23.4.779
M P Fink, D R Snydman, M S Niederman, K V Leeper, R H Johnson, S O Heard, R G Wunderink, J W Caldwell, J J Schentag, G A Siami, Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrobial Agents and Chemotherapy. ,vol. 38, pp. 547- 557 ,(1994) , 10.1128/AAC.38.3.547
Andreas Stein, Didier Raoult, Colistin: an antimicrobial for the 21st century? Clinical Infectious Diseases. ,vol. 35, pp. 901- 902 ,(2002) , 10.1086/342570
Nicolas Troillet, Matthew H. Samore, Yehuda Carmeli, Imipenem-Resistant Pseudomonas aeruginosa: Risk Factors and Antibiotic Susceptibility Patterns Clinical Infectious Diseases. ,vol. 25, pp. 1094- 1098 ,(1997) , 10.1086/516092
Thomas Fekete, Haitham Tumah, John Woodwell, Vilas Satishchandran, Allan Truant, Peter Axelrod, Comparative susceptibilities of Klebsieila species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital The American Journal of Medicine. ,vol. 100, pp. 20- 25 ,(1996) , 10.1016/S0002-9343(96)00104-0
Megan Hilf, Victor L. Yu, Joann Sharp, Jeffrey J. Zuravleff, Joyce A. Korvick, Robert R. Muder, Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. The American Journal of Medicine. ,vol. 87, pp. 540- 546 ,(1989) , 10.1016/S0002-9343(89)80611-4
Francesc Vidal, Epidemiology and Outcome of Pseudomonas aeruginosa Bacteremia, With Special Emphasis on the Influence of Antibiotic Treatment Archives of Internal Medicine. ,vol. 156, pp. 2121- 2126 ,(1996) , 10.1001/ARCHINTE.1996.00440170139015
K. L. Jacobson, S. H. Cohen, J. F. Inciardi, J. H. King, W. E. Lippert, T. Iglesias, C. J. VanCouwenberghe, The Relationship Between Antecedent Antibiotic Use and Resistance to Extended-Spectrum Cephalosporins in Group I β-Lactamase-Producing Organisms Clinical Infectious Diseases. ,vol. 21, pp. 1107- 1113 ,(1995) , 10.1093/CLINIDS/21.5.1107